Bioprogress General Discussion

Gary has a point that a modest % (say 3%) of a blockbuster drug for a single TTP is still $30m to the bottom line. That is possible with tabwrap's 4 TTP deals under negotiation. We know 2 have already passed stability trials. We have yet to be informed about the other 2.

If tabwrap can solve problems with the TTP's existing blockbusters, like BPRG say it can, then BPRG can be justified in expecting a % of royalties on sales, I would’ve thought.

Start doing the math and the figures start to look extremely impressive to the point of incredulity, yet there they are.

So what would the SP be then?

Is the installation of the machine and the subsequent standard testing to make sure it all works OK, the final hurdle before BPRG announce a TTP deal?

We don’t know, but at some stage BPRG have to announce something in regards to these deals.